ID   PDIA6_HUMAN             Reviewed;         440 AA.
AC   Q15084; B3KY95; B5MCQ5; B7Z254; B7Z4M8; F8WA83; Q53RC7; Q6ZSH5;
AC   Q99778;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   10-MAY-2017, entry version 189.
DE   RecName: Full=Protein disulfide-isomerase A6;
DE            EC=5.3.4.1 {ECO:0000269|PubMed:12204115, ECO:0000269|PubMed:15466936};
DE   AltName: Full=Endoplasmic reticulum protein 5;
DE            Short=ER protein 5;
DE            Short=ERp5;
DE   AltName: Full=Protein disulfide isomerase P5;
DE   AltName: Full=Thioredoxin domain-containing protein 7;
DE   Flags: Precursor;
GN   Name=PDIA6; Synonyms=ERP5, P5, TXNDC7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7590364; DOI=10.1016/0378-1119(95)00474-K;
RA   Hayano T., Kikuchi M.;
RT   "Cloning and sequencing of the cDNA encoding human P5.";
RL   Gene 164:377-378(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3; 4 AND 5),
RP   AND VARIANT ARG-214.
RC   TISSUE=Amygdala, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-440 (ISOFORM 1), AND
RP   VARIANT ARG-214.
RC   TISSUE=Brain;
RX   PubMed=9110174;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [7]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 20-38.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective
RT   labeling of protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-34, FUNCTION, ENZYME ACTIVITY, INTERACTION WITH
RP   ITGB3, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15466936; DOI=10.1182/blood-2004-02-0608;
RA   Jordan P.A., Stevens J.M., Hubbard G.P., Barrett N.E., Sage T.,
RA   Authi K.S., Gibbins J.M.;
RT   "A role for the thiol isomerase protein ERP5 in platelet function.";
RL   Blood 105:1500-1507(2005).
RN   [9]
RP   PROTEIN SEQUENCE OF 103-138; 195-212; 217-231; 242-289; 314-328 AND
RP   374-386.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (OCT-2004) to UniProtKB.
RN   [10]
RP   FUNCTION, ENZYME ACTIVITY, AND MUTAGENESIS OF CYS-55; CYS-58; CYS-190
RP   AND CYS-193.
RX   PubMed=12204115; DOI=10.1093/oxfordjournals.jbchem.a003242;
RA   Kikuchi M., Doi E., Tsujimoto I., Horibe T., Tsujimoto Y.;
RT   "Functional analysis of human P5, a protein disulfide isomerase
RT   homologue.";
RL   J. Biochem. 132:451-455(2002).
RN   [11]
RP   COMPONENT OF A CHAPERONE COMPLEX.
RX   PubMed=12475965; DOI=10.1091/mbc.E02-05-0311;
RA   Meunier L., Usherwood Y.-K., Chung K.T., Hendershot L.M.;
RT   "A subset of chaperones and folding enzymes form multiprotein
RT   complexes in endoplasmic reticulum to bind nascent proteins.";
RL   Mol. Biol. Cell 13:4456-4469(2002).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   INTERACTION WITH MICA.
RX   PubMed=17495932; DOI=10.1038/nature05768;
RA   Kaiser B.K., Yim D., Chow I.-T., Gonzalez S., Dai Z., Mann H.H.,
RA   Strong R.K., Groh V., Spies T.;
RT   "Disulphide-isomerase-enabled shedding of tumour-associated NKG2D
RT   ligands.";
RL   Nature 447:482-486(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129 AND SER-428, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   PHOSPHORYLATION AT SER-156.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [27]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER GLY-19, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   STRUCTURE BY NMR OF 161-280.
RG   RIKEN structural genomics initiative (RSGI);
RT   "The solution structure of the second thioredoxin-like domain of human
RT   protein disulfide-isomerase A6.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: May function as a chaperone that inhibits aggregation of
CC       misfolded proteins. Plays a role in platelet aggregation and
CC       activation by agonists such as convulxin, collagen and thrombin.
CC       {ECO:0000269|PubMed:12204115, ECO:0000269|PubMed:15466936}.
CC   -!- CATALYTIC ACTIVITY: Catalyzes the rearrangement of -S-S- bonds in
CC       proteins. {ECO:0000269|PubMed:12204115,
CC       ECO:0000269|PubMed:15466936}.
CC   -!- SUBUNIT: Part of a large chaperone multiprotein complex comprising
CC       DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1,
CC       UGT1A1 and very small amounts of ERP29, but not, or at very low
CC       levels, CALR nor CANX. Interacts with MICA on the surface of tumor
CC       cells, leading to MICA disulfide bond reduction which is required
CC       for its release from tumor cells. Interacts with ITGB3 following
CC       platelet stimulation. {ECO:0000269|PubMed:15466936,
CC       ECO:0000269|PubMed:17495932}.
CC   -!- INTERACTION:
CC       Q13162:PRDX4; NbExp=2; IntAct=EBI-1043087, EBI-2211957;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:15466936}. Cell membrane
CC       {ECO:0000269|PubMed:15466936}. Melanosome
CC       {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV (PubMed:12643545).
CC       {ECO:0000269|PubMed:12643545}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q15084-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15084-2; Sequence=VSP_021803;
CC       Name=3;
CC         IsoId=Q15084-3; Sequence=VSP_054370;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q15084-4; Sequence=VSP_055173;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q15084-5; Sequence=VSP_055174;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in platelets (at protein level).
CC       {ECO:0000269|PubMed:15466936}.
CC   -!- SIMILARITY: Belongs to the protein disulfide isomerase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49489; BAA08450.1; -; mRNA.
DR   EMBL; AK127433; BAC86977.1; -; mRNA.
DR   EMBL; AK131234; BAG54757.1; -; mRNA.
DR   EMBL; AK289428; BAF82117.1; -; mRNA.
DR   EMBL; AK294347; BAH11740.1; -; mRNA.
DR   EMBL; AK297547; BAH12614.1; -; mRNA.
DR   EMBL; AC092687; AAY24070.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00950.1; -; Genomic_DNA.
DR   EMBL; BC001312; AAH01312.1; -; mRNA.
DR   EMBL; U79278; AAB50217.1; -; mRNA.
DR   CCDS; CCDS1675.1; -. [Q15084-1]
DR   CCDS; CCDS62852.1; -. [Q15084-3]
DR   CCDS; CCDS62853.1; -. [Q15084-4]
DR   CCDS; CCDS62854.1; -. [Q15084-2]
DR   CCDS; CCDS62855.1; -. [Q15084-5]
DR   PIR; JC4369; JC4369.
DR   RefSeq; NP_001269633.1; NM_001282704.1. [Q15084-2]
DR   RefSeq; NP_001269634.1; NM_001282705.1. [Q15084-5]
DR   RefSeq; NP_001269635.1; NM_001282706.1. [Q15084-4]
DR   RefSeq; NP_001269636.1; NM_001282707.1. [Q15084-3]
DR   RefSeq; NP_005733.1; NM_005742.3. [Q15084-1]
DR   UniGene; Hs.212102; -.
DR   UniGene; Hs.580464; -.
DR   PDB; 1X5D; NMR; -; A=161-280.
DR   PDB; 3VWW; X-ray; 1.93 A; A/B=25-140.
DR   PDB; 3W8J; X-ray; 2.10 A; A/B=20-140.
DR   PDB; 4EF0; X-ray; 1.50 A; A/B=27-140.
DR   PDB; 4GWR; X-ray; 1.81 A; A/B=160-274.
DR   PDBsum; 1X5D; -.
DR   PDBsum; 3VWW; -.
DR   PDBsum; 3W8J; -.
DR   PDBsum; 4EF0; -.
DR   PDBsum; 4GWR; -.
DR   ProteinModelPortal; Q15084; -.
DR   SMR; Q15084; -.
DR   BioGrid; 115434; 91.
DR   IntAct; Q15084; 38.
DR   MINT; MINT-3030897; -.
DR   STRING; 9606.ENSP00000272227; -.
DR   ChEMBL; CHEMBL2146308; -.
DR   iPTMnet; Q15084; -.
DR   PhosphoSitePlus; Q15084; -.
DR   SwissPalm; Q15084; -.
DR   DMDM; 2501205; -.
DR   OGP; Q15084; -.
DR   REPRODUCTION-2DPAGE; IPI00644989; -.
DR   REPRODUCTION-2DPAGE; Q15084; -.
DR   EPD; Q15084; -.
DR   PaxDb; Q15084; -.
DR   PeptideAtlas; Q15084; -.
DR   PRIDE; Q15084; -.
DR   DNASU; 10130; -.
DR   Ensembl; ENST00000272227; ENSP00000272227; ENSG00000143870. [Q15084-1]
DR   Ensembl; ENST00000381611; ENSP00000371024; ENSG00000143870. [Q15084-4]
DR   Ensembl; ENST00000404371; ENSP00000385385; ENSG00000143870. [Q15084-2]
DR   Ensembl; ENST00000404824; ENSP00000384459; ENSG00000143870. [Q15084-5]
DR   Ensembl; ENST00000540494; ENSP00000438778; ENSG00000143870. [Q15084-3]
DR   Ensembl; ENST00000617249; ENSP00000481892; ENSG00000143870. [Q15084-2]
DR   GeneID; 10130; -.
DR   KEGG; hsa:10130; -.
DR   UCSC; uc002rau.5; human. [Q15084-1]
DR   CTD; 10130; -.
DR   DisGeNET; 10130; -.
DR   GeneCards; PDIA6; -.
DR   HGNC; HGNC:30168; PDIA6.
DR   HPA; CAB034347; -.
DR   HPA; HPA034652; -.
DR   HPA; HPA034653; -.
DR   MIM; 611099; gene.
DR   neXtProt; NX_Q15084; -.
DR   OpenTargets; ENSG00000143870; -.
DR   PharmGKB; PA134977905; -.
DR   eggNOG; KOG0191; Eukaryota.
DR   eggNOG; COG0526; LUCA.
DR   GeneTree; ENSGT00860000133723; -.
DR   HOGENOM; HOG000012631; -.
DR   HOVERGEN; HBG053548; -.
DR   InParanoid; Q15084; -.
DR   KO; K09584; -.
DR   OMA; TAHQSKA; -.
DR   OrthoDB; EOG091G07Z0; -.
DR   PhylomeDB; Q15084; -.
DR   TreeFam; TF315231; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   ChiTaRS; PDIA6; human.
DR   EvolutionaryTrace; Q15084; -.
DR   GenomeRNAi; 10130; -.
DR   PRO; PR:Q15084; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143870; -.
DR   CleanEx; HS_PDIA6; -.
DR   ExpressionAtlas; Q15084; baseline and differential.
DR   Genevisible; Q15084; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015037; F:peptide disulfide oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; IBA:GO_Central.
DR   GO; GO:0043277; P:apoptotic cell clearance; IBA:GO_Central.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IBA:GO_Central.
DR   InterPro; IPR005788; Disulphide_isomerase.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR017937; Thioredoxin_CS.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF00085; Thioredoxin; 2.
DR   SUPFAM; SSF52833; SSF52833; 3.
DR   TIGRFAMs; TIGR01126; pdi_dom; 2.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS00194; THIOREDOXIN_1; 2.
DR   PROSITE; PS51352; THIOREDOXIN_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Chaperone;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Endoplasmic reticulum; Isomerase; Membrane; Phosphoprotein;
KW   Polymorphism; Redox-active center; Reference proteome; Repeat; Signal.
FT   SIGNAL        1     19       {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:15466936,
FT                                ECO:0000269|PubMed:19892738}.
FT   CHAIN        20    440       Protein disulfide-isomerase A6.
FT                                /FTId=PRO_0000034236.
FT   DOMAIN       20    133       Thioredoxin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   DOMAIN      154    287       Thioredoxin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   MOTIF       437    440       Prevents secretion from ER.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   COMPBIAS    422    434       Asp/Glu-rich (acidic).
FT   ACT_SITE     55     55       Nucleophile. {ECO:0000250}.
FT   ACT_SITE     58     58       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    190    190       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    193    193       Nucleophile. {ECO:0000250}.
FT   SITE         56     56       Contributes to redox potential value.
FT                                {ECO:0000250}.
FT   SITE         57     57       Contributes to redox potential value.
FT                                {ECO:0000250}.
FT   SITE        118    118       Lowers pKa of C-terminal Cys of first
FT                                active site. {ECO:0000250}.
FT   SITE        191    191       Contributes to redox potential value.
FT                                {ECO:0000250}.
FT   SITE        192    192       Contributes to redox potential value.
FT                                {ECO:0000250}.
FT   SITE        256    256       Lowers pKa of C-terminal Cys of second
FT                                active site. {ECO:0000250}.
FT   MOD_RES     129    129       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     156    156       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     428    428       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   DISULFID     55     58       Redox-active. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   DISULFID    190    193       Redox-active. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   VAR_SEQ       1      6       MALLVL -> MRRDLREKLVWVCRPLAPVEVPANISSDFQP
FT                                CSPTSPAHSLSRKSPIMYPSTTMANAP (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_021803.
FT   VAR_SEQ       1      6       MALLVL -> MYPSTTMANAP (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055173.
FT   VAR_SEQ       1      6       MALLVL -> MRIITAPASKVSRGSNELMILARRSDRGSPT
FT                                SPAHSLSRKSPIMYPSTTMANAP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055174.
FT   VAR_SEQ       1      5       MALLV -> MI (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054370.
FT   VARIANT     214    214       K -> R (in dbSNP:rs4807).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9110174}.
FT                                /FTId=VAR_022152.
FT   MUTAGEN      55     55       C->S: 50% decrease in enzyme activity;
FT                                when associated with S-58. Abolishes
FT                                enzyme activity; when associated with S-
FT                                58; S-190 and S-193.
FT                                {ECO:0000269|PubMed:12204115}.
FT   MUTAGEN      58     58       C->S: 50% decrease in enzyme activity;
FT                                when associated with S-55. 90% decrease
FT                                in enzyme activity; when associated with
FT                                S-193. Abolishes enzyme activity; when
FT                                associated with S-55; S-190 and S-193.
FT                                {ECO:0000269|PubMed:12204115}.
FT   MUTAGEN     190    190       C->S: 25% decrease in enzyme activity;
FT                                when associated with S-193. Abolishes
FT                                enzyme activity; when associated with S-
FT                                55; S-58 and S-193.
FT                                {ECO:0000269|PubMed:12204115}.
FT   MUTAGEN     193    193       C->S: 90% decrease in enzyme activity;
FT                                when associated with S-58. 25% decrease
FT                                in enzyme activity; when associated with
FT                                S-190. Abolishes enzyme activity; when
FT                                associated with S-55; S-58 and S-190.
FT                                {ECO:0000269|PubMed:12204115}.
FT   CONFLICT     64     64       E -> K (in Ref. 2; BAH12614).
FT                                {ECO:0000305}.
FT   CONFLICT    187    187       A -> V (in Ref. 2; BAH12614).
FT                                {ECO:0000305}.
FT   STRAND       28     30       {ECO:0000244|PDB:4EF0}.
FT   TURN         32     34       {ECO:0000244|PDB:4EF0}.
FT   HELIX        35     38       {ECO:0000244|PDB:4EF0}.
FT   TURN         39     41       {ECO:0000244|PDB:4EF0}.
FT   STRAND       46     51       {ECO:0000244|PDB:4EF0}.
FT   HELIX        56     71       {ECO:0000244|PDB:4EF0}.
FT   TURN         72     75       {ECO:0000244|PDB:4EF0}.
FT   STRAND       76     82       {ECO:0000244|PDB:4EF0}.
FT   TURN         83     85       {ECO:0000244|PDB:4EF0}.
FT   HELIX        87     92       {ECO:0000244|PDB:4EF0}.
FT   STRAND      100    104       {ECO:0000244|PDB:4EF0}.
FT   STRAND      112    114       {ECO:0000244|PDB:3VWW}.
FT   HELIX       120    139       {ECO:0000244|PDB:4EF0}.
FT   STRAND      162    164       {ECO:0000244|PDB:4GWR}.
FT   TURN        167    169       {ECO:0000244|PDB:4GWR}.
FT   HELIX       170    173       {ECO:0000244|PDB:4GWR}.
FT   TURN        174    176       {ECO:0000244|PDB:4GWR}.
FT   STRAND      178    186       {ECO:0000244|PDB:4GWR}.
FT   HELIX       191    211       {ECO:0000244|PDB:4GWR}.
FT   STRAND      214    221       {ECO:0000244|PDB:4GWR}.
FT   HELIX       222    224       {ECO:0000244|PDB:4GWR}.
FT   HELIX       226    231       {ECO:0000244|PDB:4GWR}.
FT   STRAND      236    243       {ECO:0000244|PDB:4GWR}.
FT   STRAND      247    252       {ECO:0000244|PDB:1X5D}.
FT   HELIX       258    271       {ECO:0000244|PDB:4GWR}.
SQ   SEQUENCE   440 AA;  48121 MW;  06895409F0265D7C CRC64;
     MALLVLGLVS CTFFLAVNGL YSSSDDVIEL TPSNFNREVI QSDSLWLVEF YAPWCGHCQR
     LTPEWKKAAT ALKDVVKVGA VDADKHHSLG GQYGVQGFPT IKIFGSNKNR PEDYQGGRTG
     EAIVDAALSA LRQLVKDRLG GRSGGYSSGK QGRSDSSSKK DVIELTDDSF DKNVLDSEDV
     WMVEFYAPWC GHCKNLEPEW AAAASEVKEQ TKGKVKLAAV DATVNQVLAS RYGIRGFPTI
     KIFQKGESPV DYDGGRTRSD IVSRALDLFS DNAPPPELLE IINEDIAKRT CEEHQLCVVA
     VLPHILDTGA AGRNSYLEVL LKLADKYKKK MWGWLWTEAG AQSELETALG IGGFGYPAMA
     AINARKMKFA LLKGSFSEQG INEFLRELSF GRGSTAPVGG GAFPTIVERE PWDGRDGELP
     VEDDIDLSDV ELDDLGKDEL
//
